Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.

Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.

OBJECTIVE: To evaluate the efficacy/safety of subcutaneous (SC) golimumab in patients with rheumatoid arthritis (RA) who previously received intravenous (IV) golimumab with or without methotrexate (MTX). METHODS: Adult patients with RA (n = 643) with persistent disease despite MTX (≥ 15 mg/wk for ≥...

書目詳細資料
Main Authors:	Taylor, P, Ritchlin, C, Mendelsohn, A, Baker, D, Kim, L, Xu, Z, Mack, M, Kremer, J
格式:	Journal article
語言:	English
出版:	2011

相似書籍

THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
由: L. A. Knyazeva, et al.
出版: (2018-03-01)

Golimumab for the treatment of psoriatic arthritis
由: H Yang, et al.
出版: (2011-05-01)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
由: Proton Rahman, et al.
出版: (2020-09-01)

Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.
由: Kremer, J, et al.
出版: (2010)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
由: M. Rossini, et al.
出版: (2015-03-01)

Golimumab in the treatment of psoriatic arthritis: efficacy and safety
由: Tatiana Viktorovna Korotaeva, et al.
出版: (2015-09-01)

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
由: Aaron Broadwell, et al.
出版: (2023-03-01)

GOLIMUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
由: Wordsworth, P, et al.
出版: (2009)

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
由: Natalia Vladimirovna Chichasova
出版: (2014-12-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
由: M. Elaine Husni, et al.
出版: (2022-03-01)

Long-term results of golimumab therapy for rheumatoid arthritis. Therapy compliance issues
由: N. V. Chichasova
出版: (2016-06-01)

Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
由: John Tesser, et al.
出版: (2019-08-01)

GOLIMUMAB SAFETY ACCORDING TO CLINICAL FINDINGS
由: G. V. Lukina, et al.
出版: (2015-04-01)

EFFECT OF GOLIMUMAB ON IMMUNOLOGICAL MARKERS FOR BONE METABOLISM AND ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
由: L. A. Knyazeva, et al.
出版: (2018-07-01)

Golimumab Therapy in Ulcerative Colitis
由: Won Moon
出版: (2016-02-01)

Golimumab in the treatment of ulcerative colitis
由: Georgina Cunningham, et al.
出版: (2019-01-01)

Golimumab for the treatment of ulcerative colitis
由: Löwenberg M, et al.
出版: (2014-03-01)

Golimumab in unresponsive ulcerative colitis
由: Lippert E, et al.
出版: (2014-05-01)

Persistence and Safety of Golimumab in Elderly Patients with Rheumatoid Arthritis and Renal Dysfunction in a Real-World Setting
由: Seiji Yokoyama, et al.
出版: (2022-11-01)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
由: Sofia Lanz, et al.
出版: (2021-08-01)

Safety and clinical efficacy of golimumab in the treatment of arthritides
由: Ismail Simsek, et al.
出版: (2010-09-01)

The abilities of golimumab in the therapy of ankylosing spondylitis
由: Sh. F. Erdes
出版: (2014-09-01)

Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations
由: Sydney Moore McIntosh, et al.
出版: (2023-07-01)

Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis
由: Federica Rivolta, et al.
出版: (2023-03-01)

Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings
由: Fumiko Yamairi, et al.
出版: (2020-08-01)

Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
由: Melissa A Michelon, et al.
出版: (2010-05-01)

Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
由: Clifton O. Bingham, et al.
出版: (2023-02-01)

20944. NEUROSARCOIDOSIS-LIKE SECUNDARIA A GOLIMUMAB
由: A. Garre Lerma, et al.
出版: (2024-11-01)

Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis
由: Kichul Shin, et al.
出版: (2022-09-01)

GOLIMUMAB, A HUMAN TNF-ALPHA mu ONOCLONAL ANTIBODY, IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF-ALPHA AGENTS (GO-AFTER STUDY)
由: Wordsworth, P, et al.
出版: (2009)

Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
由: Hirohito Shimizu, et al.
出版: (2020-02-01)

Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis
由: Jeffrey R. Curtis, et al.
出版: (2019-12-01)

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab
由: Ellis LA, et al.
出版: (2019-01-01)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
由: T. V. Dubinina, et al.
出版: (2016-09-01)

Golimumab in the treatment of inflammatory diseases: A role of immunogenicity
由: D. E. Karateev
出版: (2016-01-01)

Golimumab in the treatment of extra-skeletal manifestations of ankylosing spondylitis
由: A. B. Demina
出版: (2019-10-01)

Efficacy of golimumab in patients with refractory non-infectious panuveitis
由: Usanee Tungsattayathitthan, et al.
出版: (2024-01-01)

Golimumab pharmacokinetics in ulcerative colitis: a literature review
由: Ines Harzallah, et al.
出版: (2017-01-01)

Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open‐Label Extension of a Randomized Clinical Trial
由: Paul Emery, et al.
出版: (2020-11-01)

A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan
由: Masahiko Miyashiro, et al.
出版: (2023-02-01)